Myocardial tumor necrosis factor-α secretion in hypertensive and heart failure-prone rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Bergman, Marina R ^a,c   Kao, Ruey H ^a   McCune, Sylvia A ^a   Holycross, Bethany J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amrinone; Phosphodiesterase inhibitors; RO 201724; SHHF Mcc fa(cp) rats; Spontaneously hypertensive rats

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; AMRINONE; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CYTOKINE RELEASE; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART SIZE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0032878743     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.2.h543     Document Type: Article

References (42)

1. Anversa, P., T. Palackal, E. H. Sonnenblick, G. Olivetti, L. G. Meggs, and J. M. Capasso. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ. Res. 67: 871-885, 1990.
2. Armendariz-Borunda, J., K. Katayama, and J. M. Seyer. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1β, tumor necrosis factor α, and transforming growth factor β in Ito cells. J. Biol. Chem. 267: 14316-14321, 1992.
3. Bachetti, T., A. Corti, A. Giordano, and R. Ferrari. Tumor necrosis factor-α in chronic heart failure. In: Mechanisms of Heart Failure, edited by P. K. Singal, I. M. C. Dixon, R. E. Beamish, and N. S. Dhalla. Boston, MA: Kluwer Academic, 1995, p. 3-8.
4. Belmin, J., C. Bernard, B. Corman, R. Merval, B. Esposito, and A. Tedgui. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2288-H2293, 1995.
5. Benet, L. Z., S. Oie, and J. B. Schwartz. Design and optimization of dosage regimens; pharmacokinetic data. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, edited by J. G. Hardman and L. E. Limbird. New York: McGraw Hill, 1996, p. 1707-1792.
6. Bergman, M. R., and B. J. Holycross. Pharmacological modulation of myocardial tumor necrosis factor a production by phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther. 279: 247-254, 1996.
7. Bienkowski, R. S., and M. G. Gotkin. Growth factor-mediated regulation of myocardial collagen gene expression. In: Molecular Biology of Collagen Matrix in the Heart, edited by M. Eghbali-Webb. Austin, TX: Landes, 1995, p. 77-92.
8. Bourassa, M. G., O. Gurne, S. I. Bangdiwala, J. K. Ghali, J. B. Young, M. Rousseau, D. E. Johnstone, and S. Yusuf. Natural history and patterns of current practice in heart failure. J. Am. Coll. Cardiol. 22:14A-19A, 1993.
9. Burton, K. Determination of DNA concentration with diphenylamine. Methods Enzymol. 12B: 163-166, 1968.
10. Canepari, M., B. Polla, M. R. Gualea, C. Zanardi, and C. Reggiani. Age-dependent reduction of the response of rat cardiac muscle to the phosphodiesterase inhibitor milrinone. Arch. Int. Physiol. Biochim. Biophys. 102: 265-269, 1994.
11. Cohn, J. N. The prevention of heart failure - a new agenda. N. Engl. J. Med. 327: 725-727, 1992.
12. Coito, A. J., J. Binder, L. F. Brown, M. de Sousa, L. Van de Water, and J. W. Kupiec-Weglinski. TNF-α upregulates the expression of fibronectin in acutely rejecting rat cardiac allografts. Transplant. Proc. 27: 463-465, 1995.
13. Diaz, A., E. Munoz, R. Johnston, J. H. Korn, and S. A. Jimenez. Regulation of human lung fibroblast α1(I) procollagen gene expression by tumor necrosis factor α, interleukin-1β, and prostaglandin E2. J. Biol. Chem. 268:10364-10371, 1993.
14. Ferrari, R., T. Bachetti, R. Confortini, C. Opasich, O. Febo, A. Corti, G. Cassani, and O. Visioli. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 1479-1486, 1995.
15. Foster, K. D., C. A. Conn, and M. J. Kluger. Fever, tumor necrosis factor, and interleukin-6 in young, mature, and aged Fischer 344 rats. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R211-R215, 1992.
16. Gerdes, A. M., T. Onodera, X. Wang, and S. A. McCune. Myocyte remodeling during the progression to failure in rats with hypertension. Hypertension 28: 609-614, 1996.
17. Giroir, B. P., and B. Beutler. Effect of amrinone on tumor necrosis factor production in endotoxic shock. Circ. Shock 36: 200-207, 1992.
18. Giroir, B. P., J. H. Johnson, T. Brown, G. L. Allen, and B. Beutler. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90: 693-698, 1992.
19. Haas, G. J., S. A. McCune, D. M. Brown, and R. J. Cody. Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model. Am. Heart J. 130: 806-811, 1995.
20. Hohl, C. M., B. Hu, R. H. Fertel, J. C. Russell, S. A. McCune, and R. A. Altschuld. Effects of obesity and hypertension on ventricular myocytes: comparison of cells from adult SHHF/ Mcc-cp and JCR:LA-cp rats. Cardiovasc. Res. 27: 238-242, 1993.
21. Holobaugh, P. A., and D. C. McChesney. Effect of anticoagulants and heat on the detection of tumor necrosis factor in murine blood. J. Immunol. Methods 135: 95-99, 1990.
22. cP) rats. Am. J. Physiol. 273 (Heart Circ. Physiol. 42) H228-H233, 1997.
23. Kapadia, S. R., H. Oral, J. Lee, M. Nakano, G. E. Taffet, and D. L. Mann. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ. Res. 81: 187-195, 1997.
24. Klein, R. M., B. K. MacGillivray, and J. C. McKenzie. Markers of cardiac hypertrophy. Ann. NY Acad. Sci. 752: 210-217, 1995.
25. Levine, B., J. Kalman, L. Mayer, H. M. Fillit, and M. Packer. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323: 236-241, 1990.
26. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
27. Matthews, N., and M. L. Neale. Cytotoxicity assays for tumour necrosis factor and lymphotoxin. In: Lymphokines and Interferons. A Practical Approach, edited by M. J. Clemens, A. G. Morris, and A. J. H. Gearing. Washington, D.C.: IRL, 1987, p. 221-225.
28. McCune, S. A., P. B. Baker, and H. F. Stills. SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 32: 23-27, 1990.
29. cp rat model: a genetic model of congestive heart failure. In: Mechanisms of Heart Failure, edited by P. K. Singal, I. M. C. Dixon, R. E. Beamish, and N. S. Dhalla. Boston, MA: Kluwer Academic, 1995, p. 91-106.
30. McMurray, J., I. Abdullah, H. J. Dargie, and D. Shapiro. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br. Heart J. 66: 356-358, 1991.
31. Molnar-Kimber, K., L. Yonno, R. Heaslip, and B. Weichman. Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 39: C77-C79, 1993.
32. Mondon, C. E., and H. F. Starnes. Differential metabolic responses to tumor necrosis factor with increase in age. Metabolism 41: 970-981, 1992.
33. Natanson, C., P. W. Eichenholz, R. L. Danner, P. Q. Eichacker, W. D. Hoffman, G. C. Kuo, S. M. Banks, T. J. MacVittie, and J. E. Parrillo. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169: 823-832, 1989.
34. Oral, H., S. Kapadia, M. Nakano, G. Torre-Amione, J. Lee, D. Lee-Jackson, J. B. Young, and D. L. Mann. Tumor necrosis factor-α and the failing human heart. Clin. Cardiol. 18: IV-20-IV-27, 1995.
35. Packer, M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 92: 1379-1382, 1995.
36. Semmler, J., U. Gebert, T. Eisenhut, J. Moeller, M. M. Schonharting, A. Allera, and S. Endres. Xanthine derivatives: comparison between suppression of tumour necrosis factor-α production and inhibition of cAMP phosphodiesterase activity. Immunology 78: 520-525, 1993.
37. Semmler, J., H. Wachtel, and S. Endres. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells. Int. J. Immunopharmacol. 15: 409-413, 1993.
38. Silver, P. J., R. J. Gordon, R. A. Buchholz, R. L. Dundore, E. W. Ferguson, A. L. Harris, and E. D. Pagani. Comparative studies on cyclic nucleotide phosphodiesterases and inhibitors in experimental models of hypertension, congestive heart failure, and allergic asthma. Adv. Second Messenger Phosphoprotein Res. 25: 341-351, 1992.
39. Smith, C. J., D. Sun, C. Hoegler, G. Zhao, X. Xu, and R. A. Moggio. Reduced gene expression of the cyclic GMP-inhibited, cyclic AMP phosphodiesterase III in canine heart failure (Abstract). Circulation 90:1-425, 1994.
40. Thiedemann, K. U., C. Holubarsch, I. Medugorac, and R. Jacob. Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical and mechanical parameters. Basic Res. Cardiol. 78: 140-155, 1983.
41. Torre-Amione, G., S. Kapadia, C. Benedict, H. Oral, J. B. Young, and D. L. Mann. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J. Am. Coll. Cardiol. 27: 1201-1206, 1996.
42. Torre-Amione, G., S. Kapadia, J. Lee, J. B. Durand, R. D. Bies, J. B. Young, and D. L. Mann. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704-711, 1996.